Biomarkers in Motor Neuron Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 300
Special Issue Editor
2. Neurology Unit, Department of Neuroscience, Azienda Ospedaliero Universitaria di Modena, 41126 Modena, Italy
Interests: amyotrophic lateral sclerosis; neurological diseases; neuroepidemiology; neurodegeneration; neuroinflammation; neurogenetics; microbiota
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases are characterized by extreme genetic, pathology, and phenotype heterogeneity, which is one of the major causes of clinical trial failure and substantial absence of effective treatments. Although different potential candidate biomarkers of disease have been the object of recent research, their use in clinics and trials is still limited.
If a diagnostic biomarker were to decrease diagnostic delay, allowing for earlier treatments, prognostic biomarkers would help in patients’ counselling and stratification in clinical trials. Pharmacodynamic and predictive biomarkers would be very useful as well, in translational and clinical research.
This Special Issue aims to collect high-quality papers on emerging research on biomarkers in motor neuron diseases, with special consideration of neurodegeneration and neuroinflammation processes and biological and clinical heterogeneity. We believe this field will take advantage of multidisciplinary approaches; hence, contributions including basic, translational, and clinical studies are strongly encouraged.
Prof. Dr. Jessica Mandrioli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- motor neuron diseases
- dementia
- neurodegeneration
- epidemiology
- pathomechanisms
- neuroinflammation
- neuroimmunology
- gut–brain axis
- disease heterogeneity
- prognosis
- biomarkers
